Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2017

01-01-2017 | Meta-Analysis

Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis

Authors: Yanjue Shen, Rongrong Cai, Jie Sun, Xue Dong, Rong Huang, Sai Tian, Shaohua Wang

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Diabetes mellitus is a strong risk factor for chronic kidney disease and end-stage renal disease. Whether sex differences in chronic kidney disease and end-stage renal disease incidence exist among diabetic patients remains unclear. This systematic review and meta-analysis was conducted to evaluate the relative effect of diabetes on chronic kidney disease and end-stage renal disease risk in women compared with men. We systematically searched Embase, PubMed, and the Cochrane Library for both cohort and case–control studies until October 2015. Studies were selected if they reported a sex-specific relationship between diabetes mellitus and chronic kidney disease or end-stage renal disease. We generated pooled estimates across studies using random-effects meta-analysis after log transformation with inverse variance weighting. Ten studies with data from more than 5 million participants were included. The pooled adjusted risk ratio of chronic kidney disease associated with diabetes mellitus was 3.34 (95 % CI 2.27, 4.93) in women and 2.84 (95 % CI 1.73, 4.68) in men. The data showed no difference in diabetes-related chronic kidney disease risk between the sexes (pooled adjusted women-to-men relative risk ratio was 1.14 [95 % CI 0.97, 1.34]) except for end-stage renal disease—the pooled adjusted women-to men relative risk ratio was 1.38 (95 % CI 1.22, 1.55; p = 0.114, I² = 38.1 %). The study found no evidence of a sex difference in the association between diabetes mellitus and chronic kidney disease. However, the excess risk for end-stage renal disease was higher in women with diabetes than in men with the same condition, from which we assume that the female gender could accelerate the disease progression. Further studies are needed to support this notion and elucidate the underlying mechanisms.
Appendix
Available only for authorised users
Literature
1.
2.
3.
M. Kastarinen, A. Juutilainen, H. Kastarinen, V. Salomaa, P. Karhapaa, J. Tuomilehto, C. Gronhagen-Riska, P. Jousilahti, P. Finne, Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J. Intern. Med. 267(6), 612–620 (2010). doi:10.​1111/​j.​1365-2796.​2009.​02197.​x CrossRefPubMed
4.
Y.T. Chang, J.L. Wu, C.C. Hsu, J.D. Wang, J.M. Sung, Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009. Diabetes Care 37(1), 277–285 (2014). doi:10.​2337/​dc13-0781 CrossRefPubMed
5.
S. Nag, R. Bilous, W. Kelly, S. Jones, N. Roper, V. Connolly, All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years’ data from the South Tees Diabetes Mortality study. Diabetic Med. 24(1), 10–17 (2007). doi:10.​1111/​j.​1464-5491.​2007.​02023.​x CrossRefPubMed
6.
J. Neugarten, A. Acharya, S.R. Silbiger, Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol. 11(2), 319–329 (2000)PubMed
7.
8.
A. Mollsten, M. Svensson, I. Waernbaum, Y. Berhan, S. Schon, L. Nystrom, H.J. Arnqvist, G. Dahlquist, Swedish Childhood Diabetes Study, G., Diabetes Incidence Study in, S., Swedish Renal, R. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes 59(7), 1803–1808 (2010). doi:10.​2337/​db09-1744
9.
K. Raile, A. Galler, S. Hofer, A. Herbst, D. Dunstheimer, P. Busch, R.W. Holl, Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30(10), 2523–2528 (2007). doi:10.​2337/​dc07-0282 CrossRefPubMed
10.
P. Hovind, L. Tarnow, P. Rossing, B.R. Jensen, M. Graae, I. Torp, C. Binder, H.H. Parving, Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. Br. Med. J. 328(7448), 1105 (2004). doi:10.​1136/​bmj.​38070.​450891.​FE CrossRef
11.
12.
13.
M.C. Monti, J.T. Lonsdale, C. Montomoli, R. Montross, E. Schlag, D.A. Greenberg, Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J. Clin. Endocrinol. Metab. 92(12), 4650–4655 (2007). doi:10.​1210/​jc.​2007-1185 CrossRefPubMed
14.
P. Rossing, P. Hougaard, H.H. Parving, Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25(5), 859–864 (2002)CrossRefPubMed
15.
J.A. Breyer, R.P. Bain, J.K. Evans, N.S. Nahman Jr., E.J. Lewis, M. Cooper, J. McGill, T. Berl, Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int. 50(5), 1651–1658 (1996)CrossRefPubMed
16.
K. Okada, M. Yanai, K. Takeuchi, K. Matsuyama, K. Nitta, K. Hayashi, S. Takahashi, Sex differences in the prevalence, progression, and improvement of chronic kidney disease. Kidney Blood Press. Res. 39(4), 279–288 (2014). doi:10.​1159/​000355805 CrossRefPubMed
17.
18.
P.E. Stevens, A. Levin, Kidney disease: improving global outcomes chronic kidney disease guideline development work group, M., Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158(11), 825–830 (2013). doi:10.​7326/​0003-4819-158-11-201306040-00007 CrossRefPubMed
19.
A.S. Levey, J. Coresh, T. Greene, J. Marsh, L.A. Stevens, J.W. Kusek, F. Van Lente, Chronic Kidney Disease Epidemiology, C.: Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 53(4), 766–772 (2007). doi:10.​1373/​clinchem.​2006.​077180
20.
J.L. Teruel, J. Sabater, C. Galeano, M. Rivera, J.L. Merino, M. Fernandez Lucas, R. Marcen, J. Ortuno, [The Cockcroft-Gault equation is better than MDRD equation to estimate the glomerular filtration rate in patients with advanced chronic renal failure]. Nefrologia 27(3), 313–319 (2007)PubMed
21.
A.A. Sanusi, A. Akinsola, A.A. Ajayi, Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients. Afr. J. Med. Med. Sci. 29(1), 7–11 (2000)PubMed
22.
A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, E.P.I. Ckd, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604–612 (2009)CrossRefPubMedPubMedCentral
23.
L. Hoste, L. Dubourg, L. Selistre, V.C. De Souza, B. Ranchin, A. Hadj-Aissa, P. Cochat, F. Martens, H. Pottel, A new equation to estimate the glomerular filtration rate in children, adolescents and young adults. Nephrol. Dial. Transpl. 29(5), 1082–1091 (2014). doi:10.​1093/​ndt/​gft277 CrossRef
24.
S.A.E. Peters, R.R. Huxley, M. Woodward, Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 383(9933), 1973–1980 (2014). doi:10.​1016/​S0140-6736(14)60040-4 CrossRefPubMed
25.
26.
M. Egger, G. Davey Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315(7109), 629–634 (1997)CrossRef
27.
S. Duval, E. Weinhandl, Correcting for Publication Bias in the Presence of Covariates. Methods Research Report (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 11-EHC041-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2011. Available at: www.​effectivehealthc​are.​ahrq.​gov/​reports/​final.​cfm
28.
F. Hoffmann, B. Haastert, M. Koch, G. Giani, G. Glaeske, A. Icks, The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol. Dial. Transpl. 26(5), 1634–1640 (2011). doi:10.​1093/​ndt/​gfq609 CrossRef
29.
J.C. van Blijderveen, S.M. Straus, R. Zietse, B.H. Stricker, M.C. Sturkenboom, K.M. Verhamme, A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. Int. Urol. Nephrol. 46(3), 583–592 (2014). doi:10.​1007/​s11255-013-0563-3 CrossRefPubMed
30.
J.L. Xue, P.W. Eggers, L.Y. Agodoa, R.N. Foley, A.J. Collins, Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J. Am. Soc. Nephrol. 18(4), 1299–1306 (2007). doi:10.​1681/​ASN.​2006050524 CrossRefPubMed
31.
32.
K. Nagai, C. Saito, F. Watanabe, R. Ohkubo, C. Sato, T. Kawamura, K. Uchida, A. Hiwatashi, H. Kai, K. Ishida, T. Sairenchi, K. Yamagata, Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study. Clin. Exp. Nephrol. 17(2), 255–260 (2013). doi:10.​1007/​s10157-012-0692-5 CrossRefPubMed
33.
34.
35.
R.F. Dyck, L. Tan, Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan. Can. Med. Assoc. J. 150(2), 203–208 (1994)
36.
K. Yamagata, K. Ishida, T. Sairenchi, H. Takahashi, S. Ohba, T. Shiigai, M. Narita, A. Koyama, Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 71(2), 159–166 (2007). doi:10.​1038/​sj.​ki.​5002017 CrossRefPubMed
37.
38.
R. Retnakaran, C.A. Cull, K.I. Thorne, A.I. Adler, R.R. Holman, U.S. Group, Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes 55(6), 1832–1839 (2006). doi:10.​2337/​db05-1620 CrossRefPubMed
39.
V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, E.Z. Soliman, P.D. Sorlie, N. Sotoodehnia, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, M.B. Turner; American Heart Association Statistics, C., Stroke Statistics, S.: Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 125(1), e2–e220 (2012). doi:10.​1161/​CIR.​0b013e31823ac046​ CrossRefPubMed
40.
A.O. Luk, W.Y. So, R.C. Ma, A.P. Kong, R. Ozaki, V.S. Ng, L.W. Yu, W.W. Lau, X. Yang, F.C. Chow, J.C. Chan, P. C. Tong, Hong Kong Diabetes, R.: Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 31(12), 2357–2361 (2008). doi:10.​2337/​dc08-0971
41.
42.
G. Penno, A. Solini, E. Bonora, C. Fondelli, E. Orsi, G. Zerbini, R. Trevisan, M. Vedovato, G. Gruden, L. Laviola, A. Nicolucci, G. Pugliese, I. Renal; Cardiovascular Events Study, G.: Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J. Int. Med. 274(2), 176–191 (2013). doi:10.​1111/​joim.​12073 CrossRef
43.
D.J. Wexler, R.W. Grant, J.B. Meigs, D.M. Nathan, E. Cagliero, Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28(3), 514–520 (2005)CrossRefPubMed
44.
A. Ferrara, C.M. Mangione, C. Kim, D.G. Marrero, D. Curb, M. Stevens, J.V. Selby, Translating Research Into Action for Diabetes Study, G.: Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: translating research into action for diabetes (TRIAD) study. Diabetes Care 31(1), 69–74 (2008). doi:10.​2337/​dc07-1244
45.
S.G. Wannamethee, O. Papacosta, D.A. Lawlor, P.H. Whincup, G.D. Lowe, S. Ebrahim, N. Sattar, Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women’s Heart Health Study. Diabetologia 55(1), 80–87 (2012). doi:10.​1007/​s00125-011-2284-4 CrossRefPubMed
46.
S. Xiao, D.G. Gillespie, C. Baylis, E.K. Jackson, R.K. Dubey, Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension 37(2 Pt 2), 645–650 (2001)CrossRefPubMed
47.
48.
S. Doublier, E. Lupia, P. Catanuto, S.J. Elliot, Estrogens and progression of diabetic kidney damage. Curr. Diabetes. Rev. 7(1), 28–34 (2011)CrossRefPubMed
49.
J.F. Reckelhoff, L.L. Yanes, R. Iliescu, L.A. Fortepiani, J.P. Granger, Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am. J. Physiol. Renal. Physiol. 289(5), F941–948 (2005). doi:10.​1152/​ajprenal.​00034.​2005 CrossRefPubMed
50.
51.
52.
P. Catanuto, S. Doublier, E. Lupia, A. Fornoni, M. Berho, M. Karl, G.E. Striker, X. Xia, S. Elliot, 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 75(11), 1194–1201 (2009). doi:10.​1038/​ki.​2009.​69 CrossRefPubMed
53.
R.W. Mankhey, C.C. Wells, F. Bhatti, C. Maric, 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292(2), R769–R777 (2007). doi:10.​1152/​ajpregu.​00375.​2006 CrossRefPubMed
54.
55.
56.
57.
Metadata
Title
Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis
Authors
Yanjue Shen
Rongrong Cai
Jie Sun
Xue Dong
Rong Huang
Sai Tian
Shaohua Wang
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1014-6

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue

Original Article

The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism

Original Article

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

Endocrine Methods and Techniques

Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure

Original Article

10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas

Original Article

Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism

Original Article

Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits